Clinical Trial Update: Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma

View source ↗

Summary

A clinical trial update indicates that a study evaluating low-dose radiotherapy for primary indolent cutaneous B-cell lymphoma is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Cutaneous B-cell Lymphoma

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Primary Indolent Cutaneous B-cell Lymphoma | Status: ACTIVE_NOT_RECRUITING